MIRA Pharmaceuticals, Inc.
USD1.04
-0.01 (-0.95%)
CEO
Erez Aminov
IPO Date
2023-08-14
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
US
Open
$1.03
Prev. Close
$1.05
Day Low
$1.00
Day High
$1.05
52W Low
$0.90
52W High
$2.45
Market Cap
$0.04B
Volume
0.11M
| 234,595 |
| $1.16 |
| 17 Feb 2026 | Aminov Erez | director, officer: CEO and Chairman | M-Exempt | Acquired | 379,000 | $0.84 |
| 17 Feb 2026 | Aminov Erez | director, officer: CEO and Chairman | A-Award | Acquired | 3,155,170 | $1.45 |
| 3 Oct 2025 | Shekhat Denil Nanji | director | A-Award | Acquired | 22,378 | $1.35 |
| 3 Oct 2025 | Aminov Erez | director, officer: Chief Executive Officer | A-Award | Acquired | 2,685,456 | $0.00 |
| 18 Sept 2025 | Aminov Erez | director, officer: Chief Executive Officer | A-Award | Acquired | 150,000 | $1.38 |
| 3 Sept 2025 | Aminov Erez | director, officer: Chief Executive Officer | A-Award | Acquired | 62,500 | $1.37 |
| 10 Jun 2025 | Weichselbaum Alan | Chief Financial Officer | Disposed | 75,000 | $1.18 |
| 2 Aug 2023 | Vorhoff David C | director | Disposed | 0 | $0.00 |